Robert Uger, Chief Scientific Officer at Trillium Therapeutics, holds 0.00 shares in Trillium Therapeutics (Ticker: TRIL). Most recently, Robert Uger ― shares of Trillium Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Robert Uger?
The percentage of profitable transactions made by Robert Uger is ―.
What is the average return per transaction made by Robert Uger?
The average return per transaction made by Robert Uger is ―.
What stocks does Robert Uger hold?
Robert Uger holds: TRIL stocks.
What was Robert Uger’s latest transaction?
Robert Uger latest transaction was an Uninformative Buy of ―.
What was Robert Uger's most profitable transaction?
Robert Uger’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert Uger's role in Trillium Therapeutics?
Robert Uger's role in Trillium Therapeutics is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.